Error loading player: No playable sources found

Player size: small large

Potent Vaccine Efficacy from mRNA‑1273 Expressing SARS‑CoV‑2 Spike Protein Stabilized in the Prefusion Conformation

Date

January 14, 2021

Speaker

Andrea Carfi, PhD

Moderna

Tracks

Vaccines as Drugs for COVID‑19

Related Products

Thumbnail for Development of the mRNA based SARS-CoV-2 Vaccine CVnCoV

Development of the mRNA based SARS-CoV-2 Vaccine CVnCoV

Thumbnail for Closing Remarks

Closing Remarks

Thumbnail for Intranasal Vaccination with ChAdOx1 nCoV 19 Results in Reduced Nasal Shedding and Lack of Lower Respiratory Tract Infection in SARS CoV 2 Hamsters and Rhesus Macaques

Intranasal Vaccination with ChAdOx1 nCoV 19 Results in Reduced Nasal Shedding and Lack of Lower Respiratory Tract Infection in SARS CoV 2 Hamsters and Rhesus Macaques

Thumbnail for Janssen’s Efforts in the Development of an Ad26 Based COVID‑19 Vaccine

Janssen’s Efforts in the Development of an Ad26 Based COVID‑19 Vaccine

Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.